<DOC>
	<DOCNO>NCT01662128</DOCNO>
	<brief_summary>Select 600 case woman breast cancer triple negative Her-2 positive 4 axillary lymph node metastasis . All patient accept chemotherapy Anthracycline and/or Taxane . Divide two group randomly . Then experimental group treat Xeloda ( 1000mg/m2 , orally,2 times/day ) six cycle ( 21 days/cycle , take two week suspend one week ) Sequential Adjuvant Therapy . And control group receive adjuvant therapy.Finally investigator ass 5-year disease-free survival , 5 year 10-year overall survival safety use medication .</brief_summary>
	<brief_title>Efficacy Safety Of Xeloda Sequential Adjuvant Therapy After Chemotherapy Breast Cancer</brief_title>
	<detailed_description>The investigator select 600 case woman breast cancer triple negative Her-2 positive 4 axillary lymph node metastasis . All patient accept chemotherapy Anthracycline and/or Taxane . Divide two group randomly . Then experimental group treat Xeloda ( 1000mg/m2 , orally,2 times/day ) six cycle ( 21 days/cycle , take two week suspend one week ) Sequential Adjuvant Therapy . And control group receive adjuvant therapy.Finally investigator ass 5-year disease-free survival , 5 year 10-year overall survival safety use medication .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . Karnofsky ≥ 70 2 . Provision inform consent 3 . Pathological confirmation breast cancer exclusion metastasis . 4 . Pathological confirmation triple negative Her2 positive 4 axillary lymph node metastasis 5 . The patient finish chemotherapy Anthracycline and/or Taxane.And 's 28 day accept last chemotherapy . 6 . Laboratory criterion : PLT ≥ 100*109/L WBC ≥ 4000/mm3 HGB ≥ 10g/dl GOT , GPT , ALP ≤ 2*ULN TBIL , DBIL , CCr ≤ 1.5*ULN 1 . Pregnant lactation woman 2 . Bilateral breast cancer , inflammatory breast cancer carcinoma situ 3 . Accepted neoadjuvant treatment include chemotherapy , radiotherapy endocrine therapy 4 . History organ transplantation 5 . With mental disease 6 . With severe infection active gastrointestinal ulcer 7 . With severe liver disease ( cirrhosis ) , kidney disease , respiratory disease diabetes 8 . Diseasefree period malignant tumor le 5 year ( except cure basal cell skin cancer cervical carcinoma situ ) 9 . With heart disease 10 . Experimental drug allergy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Breast Cancer</keyword>
</DOC>